Impact of preoperative wait time on survival in patients with clinical stage II/III gastric cancer

Gastric Cancer

Volumn 22, Issue 4, 2019, Pages 864-872

  Furukawa, Kenichiro ^a   Irino, Tomoyuki ^a   Makuuchi, Rie ^a   Koseki, Yusuke ^a   Nakamura, Kenichi ^a   Waki, Yuhei ^a   Fujiya, Keiichi ^a   Omori, Hayato ^a   Tanizawa, Yutaka ^a   Bando, Etsuro ^a   Kawamura, Taiichi ^a   Terashima, Masanori ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Gastric cancer; Preoperative wait time; Surgery; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HEALTH IMPACT ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PREOPERATIVE WAIT TIME; PRIORITY JOURNAL; STOMACH CANCER; THERAPY DELAY; FOLLOW UP; HOSPITAL ADMISSION; MIDDLE AGED; MORTALITY; PATHOLOGY; PREOPERATIVE CARE; RISK FACTOR; STOMACH TUMOR; SURVIVAL RATE; TIME FACTOR;

AGED; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREOPERATIVE CARE; RISK FACTORS; STOMACH NEOPLASMS; SURVIVAL RATE; TIME FACTORS; WAITING LISTS;

EID: 85058351777     PISSN: 14363291     EISSN: 14363305     Source Type: Journal    
DOI: 10.1007/s10120-018-00910-y     Document Type: Article

References (27)

1. Cancer Research UK. Cancer waiting times. https://www.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/access-to-treatment/waiting-times-after-diagnosis.
2. Visser E, Leeftink AG, van Rossum PS, Siesling S, van Hillegersberg R, Ruurda JP. Waiting time from diagnosis to treatment has no impact on survival in patients with esophageal cancer. Ann Surg Oncol. 2016;23:2679–89.
3. Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253:779–85.
4. Bleicher RJ, Ruth K, Sigurdson ER, Beck JR, Ross E, Wong YN, et al. Time to surgery and breast cancer survival in the United States. JAMA Oncol. 2016;2:330–9.
5. Eriksson L, Bergh J, Humphreys K, Warnberg F, Tornberg S, Czene K. Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: a population-based cohort study. Int J Cancer. 2018;143:1093–104.
6. Yun YH, Kim YA, Min YH, Park S, Won YJ, Kim DY, et al. The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery. Ann Oncol. 2012;23:2731–7.
7. Shin DW, Cho J, Kim SY, Guallar E, Hwang SS, Cho B, et al. Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer. Ann Surg Oncol. 2013;20:2468–76.
8. Miki Y, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Staging laparoscopy for patients with cM0, Type 4, and large Type 3 gastric cancer. World J Surg. 2015;39:2742–7.
9. Irino T, Sano T, Hiki N, Ohashi M, Nunobe S, Kumagai K, et al. Diagnostic staging laparoscopy in gastric cancer: a prospective cohort at a cancer institute in Japan. Surg Endosc. 2018;32:268–75.
10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83.
11. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.
12. Bando E, Makuuchi R, Tokunaga M, Tanizawa Y, Kawamura T, Terashima M. Impact of clinical tumor-node-metastasis staging on survival in gastric carcinoma patients receiving surgery. Gastric Cancer. 2017;20:448–56.
13. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.
14. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–20.
15. Feng F, Zheng G, Guo X, Liu Z, Xu G, Wang F, et al. Impact of body mass index on surgical outcomes of gastric cancer. BMC Cancer. 2018;18:151.
16. Crawford SC, Davis JA, Siddiqui NA, de Caestecker L, Gillis CR, Hole D, et al. The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland. BMJ. 2002;325:196.
17. Kotz BS, Croft S, Ferry DR. Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? A study based on West Midlands cancer registration data. Br J Cancer. 2006;95:835–40.
18. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, et al. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015;125:424–33.
19. Diaconescu R, Lafond C, Whittom R. Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol. 2011;6:1254–9.
20. Korets R, Seager CM, Pitman MS, Hruby GW, Benson MC, McKiernan JM. Effect of delaying surgery on radical prostatectomy outcomes: a contemporary analysis. BJU Int. 2012;110:211–6.
21. Gulliford MC, Petruckevitch A, Burney PG. Survival with bladder cancer, evaluation of delay in treatment, type of surgeon, and modality of treatment. BMJ. 1991;303:437–40.
22. Umezu T, Shibata K, Kajiyama H, Yamamoto E, Mizuno M, Kikkawa F. Prognostic factors in stage IA-IIA cervical cancer patients treated surgically: does the waiting time to the operation affect survival? Arch Gynecol Obstet. 2012;285:493–7.
23. Roland CL, Schwarz RE, Tong L, Ahn C, Balch GC, Yopp AC, et al. Is timing to delivery of treatment a reliable measure of quality of care for patients with colorectal adenocarcinoma? Surgery. 2013;154:421–8.
24. Kim SJ, Kim HH, Kim YH, Hwang SH, Lee HS, Park DJ, et al. Peritoneal metastasis: detection with 16- or 64-detector row CT in patients undergoing surgery for gastric cancer. Radiology. 2009;253:407–15.
25. Gray RE, Fitch MI, Phillips C, Labrecque M, Klotz L. Presurgery experiences of prostate cancer patients and their spouses. Cancer Pract. 1999;7:130–5.
26. Robinson KM, Christensen KB, Ottesen B, Krasnik A. Diagnostic delay, quality of life and patient satisfaction among women diagnosed with endometrial or ovarian cancer: a nationwide Danish study. Qual Life Res. 2012;21:1519–25.
27. Song H, Fang F, Valdimarsdottir U, Lu D, Andersson TM, Hultman C, et al. Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study. BMC Cancer. 2017;17:2.